US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist

0.698
+0.053+8.20%

Close Jan 3 16:00 ET

0.700
+0.002+0.29%

Post 18:59 ET

203.90MMarket Cap-0.88P/E (TTM)

Lyell Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lyell Immunopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	34.000K / 0.000	--
--	2024/Q2	13.000K / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q334.000K / 0.000--

--2024/Q213.000K / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Lyell Immunopharma Earnings Reports

Lyell Immunopharma | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:26 ET

Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024

Nov 7, 2024 16:14 ET

Lyell Immunopharma | 10-Q: Q2 2024 Earnings Report

Aug 7, 2024 22:19 ET

Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024

Aug 7, 2024 16:13 ET

Analyst Rating

Updated: Jan 4, 2025

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall